Medication Formulation Compatibility
Medication Formulation Compatibility is a pharmaceutical criterion that determines the suitability of a drug formulation for use in nebulizer systems by assessing its physicochemical stability, aerosolization efficiency, and absence of degradation or precipitation under nebulization conditions.
30
Publications
681
Citations
89
Authors
44
Institutions
Publications per year
2017–2026
2
Parents
30
1–5 of 30
89
The University of Texas MD Anderson Cancer Center, United States
5 publications · 117 citations
5
h-index
The University of Texas MD Anderson Cancer Center, United States
4 publications · 99 citations
4
h-index
3
h-index
3
h-index
2
h-index
1–5 of 89
44
The University of Texas MD Anderson Cancer Center
Houston, United States
4 h-index
8 publications
198 citations
Johannes Gutenberg University Mainz
Mainz, Germany
3 h-index
6 publications
77 citations
SUNY Upstate Medical University
Syracuse, United States
2 h-index
7 publications
117 citations
Universidade Federal de Minas Gerais
Belo Horizonte, Brazil
1 h-index
1 publications
13 citations

Mukogawa Women's University
Nishinomiya, Japan
1 h-index
3 publications
48 citations

Women & Children's Hospital of Buffalo
Buffalo, United States
1 h-index
3 publications
33 citations

Research Triangle Park Foundation
Durham, United States
1 h-index
1 publications
13 citations
Johnson & Johnson (United States)
New Brunswick, United States
1 h-index
1 publications
18 citations
1–8 of 44
AJHP · 10 publications · 208 citations
10
h-index
3 publications · 70 citations
3
h-index
Repository · 3 publications · 35 citations
3
h-index
2 publications · 63 citations
2
h-index
1 publications · 96 citations
1
h-index
1–5